New Discovery LLC Report issue

For profit Phase 4
Founded: New York NY United States (2011)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2011
NCT01743079
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

New Discovery LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Congenital Abnormalities (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Infections (Phase 4)

Viremia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4